Localized Ewing tumor of bone: Final results of the Cooperative Ewing's Sarcoma Study CESS 86

Journal of Clinical Oncology

Volumn 19, Issue 6, 2001, Pages 1818-1829

  Paulussen, M ^a   Ahrens, S ^a   Dunst, J ^a   Winkelmann, W ^a   Exner, G U ^a   Kotz, R ^a   Amann, G ^a   Dockhorn Dworniczak, B ^a   Harms, D ^a   Muller Weihrich S ^a   Welte, K ^a   Kornhuber, B ^a   Janka Schaub, G ^a   Gobel U ^a   Treuner, J ^a   Voute P A ^a   Zoubek, A ^a   Gadner, H ^a   Jurgens H ^a  

^a UNIVERSITY OF MÜNSTER   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

CYCLOPHOSPHAMIDE; DACTINOMYCIN; DOXORUBICIN; IFOSFAMIDE; VINCRISTINE;

ADOLESCENT; ADULT; ARTICLE; CANCER RECURRENCE; CANCER SURVIVAL; CHILD; EWING SARCOMA; FEMALE; HIGH RISK PATIENT; HUMAN; INFANT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; RISK FACTOR; SECOND CANCER; TUMOR LOCALIZATION; TUMOR VOLUME;

EID: 0035868651     PISSN: 0732183X     EISSN: None     Source Type: Journal    
DOI: 10.1200/JCO.2001.19.6.1818     Document Type: Article

References (45)

1. Curability of Ewing's sarcoma and considerations for future therapeutic trials
2. Improved outlook for Ewing's sarcoma with combination chemotherapy (vincristine, actinomycin D and cyclophosphamide) and radiation therapy
3. Prognostic significance of tumor volume in localized Ewing's sarcoma of bone in children and adolescents
4. Radiation therapy as local treatment in Ewing's sarcoma: Results of the Cooperative Ewing's Sarcoma Studies CESS 81 and CESS 86
5. Long-term results from the first UKCCSG Ewing's tumour study (ET-1)
6. Long-term follow-up of Ewing's sarcoma of bone treated with combined-modality therapy
7. Multimodal therapy for the management of primary, nonmetastatic Ewing's sarcoma of bone: A long-term follow-up of the first intergroup study
8. Therapy for localized Ewing's sarcoma of bone
9. Operation oder Radiotherapie bei prognostisch günstigen Ewing-Sarkomen? Eine Analyse der CESS-86-Daten
10. Small-cell pediatric tumors: Histology, immunohistochemistry, and electron microscopy
11. Morphological grades of regression in osteosarcoma after polychemotherapy: Study COSS 80
12. Radiation therapy in Ewing's sarcoma: An update of the CESS 86 trial
13. Nonparametric estimation from incomplete observations
14. Design and analysis of randomized clinical trials requiring prolonged observation of each patient: II. Analysis and examples
15. Regression models and lifetables
16. How to establish equivalence when data are censored: A randomized trial of treatments for B non-Hodgkin lymphoma
17. Improved methodology for analyzing local and distant recurrence
18. A multidisciplinary study investigating radiotherapy in Ewing's sarcoma: End results of POG #8346
19. Primary metastatic (stage IV) Ewing tumor: Survival analysis of 171 patients from the EICESS studies
20. Non-metastatic Ewing's sarcoma: Results in 98 patients treated with neoadjuvant chemotherapy
21. Multimodal therapy for the management of nonpelvic, localized Ewing's sarcoma of bone: Intergroup study IESS-II
22. Prognostic factors in nonmetastatic Ewing's sarcoma of bone treated with adjuvant chemotherapy: Analysis of 359 patients at the Istituto Ortopedico Rizzoli
23. Five-year results in Ewing's sarcoma: The Scandinavian Sarcoma Group experience with the SSG IX protocol
24. The response to initial chemotherapy as a prognostic factor in localized Ewing's sarcoma
25. Multidisciplinary treatment of primary Ewing's sarcoma of bone: A 6-year experience of a European Cooperative Trial
26. Local recurrence, rate and sites of metastases, and time to relapse as a function of treatment regimen, size of primary and surgical history in 62 patients presenting with nonmetastatic Ewing's sarcoma of the pelvic bones
27. Primary Ewing's sarcoma of the ribs: A report from the Intergroup Ewing's Sarcoma Study
28. Influence of prognostic factors on survival in Ewing's sarcoma
29. Prognostic factors in children with Ewing's sarcoma
30. Intergroup Ewing's Sarcoma Study: Local control related to radiation dose, volume, and site of primary lesion in Ewing's sarcoma
31. High-dose ifosfamide with mesna uroprotection in Ewing's sarcoma
32. A phase II study of ifosfamide in the treatment of recurrent sarcomas in young people
33. A phase II study of ifosfamide in children with recurrent solid tumours
34. Phase II trial of ifosfamide with mesna in previously treated metastatic sarcoma
35. Evaluation of prognostic factors in a tumor volume adapted treatment strategy for localized Ewing's sarcoma of bone: The CESS 86 experience
36. EICESS 92: Erste Ergebnisse
37. European Intergroup Cooperative Ewing's Sarcoma Study (EICESS 92): First results
38. Mobilization of tumour cells during biopsy in an infant with Ewing sarcoma
39. Ewing's sarcoma and primitive neuroectodermal tumor in adults: Are they different from Ewing's sarcoma and primitive neuroectodermal tumor in children?
40. Neoadjuvant chemotherapy for Ewing's sarcoma of bone in patients older than thirty-nine years
41. Malignant peripheral neuroectodermal tumor and its necessary distinction from Ewing's sarcoma: A report from the Kiel Pediatric Tumor Registry
42. Prognostic value of clinicopathologic characteristics including neuroectodermal differentiation in osseous Ewing's sarcoma family of tumors in children
43. Factors associated with tumor volume and primary metastases in Ewing tumors: Results from the (EI)CESS studies
44. Is neuro-ectodermal differentiation of Ewing's sarcoma of bone associated with an unfavourable prognosis?
45. Basic methods and the developing structure of a late effects surveillance system (LESS) in the long-term follow-up of pediatric cancer patients in Germany: For the German Late Effects Study Group in the German Society Pediatric Oncology and Hematology (GPOH)